0000899243-18-028970.txt : 20181114 0000899243-18-028970.hdr.sgml : 20181114 20181114210355 ACCESSION NUMBER: 0000899243-18-028970 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181109 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gerard Christopher CENTRAL INDEX KEY: 0001694097 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 181185808 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-09 0 0000896262 AMEDISYS INC AMED 0001694097 Gerard Christopher 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Operating Officer Common Stock 2018-11-09 4 M 0 7892 46.35 A 29429 D Common Stock 2018-11-09 4 S 0 5600 118.64 D 23829 D Common Stock 2018-11-09 4 S 0 2292 119.94 D 21537 D Common Stock 211 I Through 401(k) Plan Stock Option (right to buy) 46.35 2018-11-09 4 M 0 7892 0.00 D 2027-01-20 Common Stock 7892 23675 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.30 to $119.09, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.52 to $120.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The information in this report is based on a plan statement dated as of September 30, 2018. On January 20, 2017, the reporting person was granted an option to purchase 31,567 shares of common stock. The option vested as to 7,892 shares on January 20, 2018, and the remaining 23,675 options vest in equal installments on each of January 20, 2019, January 20, 2020 and January 20, 2021, provided that the reporting person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2018-11-14